abstract |
Provided herein are compounds and methods for modulating phosphodiesterase PDE 4. More specifically, selective inhibitors of PDE4 are provided, as well as the use of such inhibitors in the modulation of diseases and disorders, for example, for the treatment of cancer, inflammatory diseases, neurological diseases, neurodegenerative diseases, and addiction. |